Skip to main content

Food and Drug Law Institute (“FDLI”) 2022 Enforcement, Litigation and Compliance Conference

The Food & Drug Law Institute annual Enforcement, Litigation, and Compliance Conference brings together industry, regulators, attorneys, litigators, academics, and consultants to discuss trends and issues in enforcement and compliance, the latest developments in both civil and criminal litigation, and recent cases and settlements. James Fraser, Shareholder in the Health Care & FDA and Pharmaceutical, Medical Device and Health Care Litigation Practices, will participate in the closing conference session panel, “Updates in Litigation Risks: Product Liability, Private Litigation, and Consumer Class Actions" on Friday, December 10.